With expansion plans for its production facility and increasingly strict municipal wastewater standards, a valued client needed to upgrade and increase its wastewater treatment capability.

Haskell transformed the wastewater system into an aerobic biological treatment plant capable of processing 1.5 million gallons daily. The project increased the plant capacity by 30% and improved the quality of wastewater sent to the municipal water system for further treatment.

“The owner was so pleased with our openness of communication and efficiency that they have since engaged Haskell with multiple projects nationwide,” Haskell Project Manager Jon Fouty said. “The project was a good showcase of what Haskell can do.”

The plant modifications included the addition of a strainer in the headworks building, the replacement of all media in existing moving bed biofilm reactor (MBBR) tanks, the replacement of the MBBR blowers, a new building for the process equipment and the modification of existing supporting piping and structures. Haskell’s team installed a 1.8-million-gallon precast concrete tank, which includes an aerobic, anoxic, and membrane zone. Additionally, precast sludge storage tanks were installed to support the dewatering.

The plant remained in operation throughout the two-year project, so Haskell team members executed a complex Manual of Permitted Operations (MOPO) plan that coordinated tie-ins, equipment installations and employee and vehicle traffic, all while ensuring there was no disruption to the plant’s normal production.

The Industrial Water Market bridges the strength of Haskell’s Municipal Water Market and its range of private-sector markets, such as Food; Beverage; Healthcare; Beer, Wine & Spirits; Transportation; Consumer Products and, as in this case, Life Sciences.

In 2021, while the project was underway, Haskell launched its Life Sciences Division. Among the clients served are biopharmaceutical manufacturers seeking to expand capacity, introduce new products or streamline production.

“Having this design-build capability in-house at Haskell provides the Life Sciences team with a key offering that is in high demand with our U.S. and global clients,” said Ken Anthony, Life Sciences VP and Division Leader. “Most of our competitors do not have this capability, and it provides an important differentiator for Haskell.”

At Haskell, we take our clients’ goals as our own. We innovate constantly to ensure that we deliver world-class solutions with the best possible effectiveness, efficiency and performance. Contact us to discuss your facilities needs.